Pancreas. 2014 May;43(4):584-7. doi: 10.1097/MPA.0000000000000081.
The differential diagnosis between primary pancreatic neoplasms versus pancreatic metastases (PM) is challenging. Endoscopic ultrasonography with fine-needle aspiration can be used to differentiate primary versus metastatic tumors although with a suboptimal accuracy. Recently, contrast harmonic EUS (CH-EUS) has been reported as an adjunct in the diagnosis of pancreatic neoplasms. We evaluated the potential role of CH-EUS in the differential diagnosis of PM.
This study is a retrospective analysis of a prospectively maintained database. Of the 266 patients, 4.1% were diagnosed with PM. Endoscopic ultrasonography with fine-needle aspiration and/or surgical pathology represented our criterion standard.
The origins of PM were renal cancer (3 patients), colon cancer(2 patients), breast cancer (2 patients), ovarian cancer (1 patient), melanoma(1 patient), lymphoma (1 patient), and sarcoma (1 patient). All lesions appeared hypoechoic at standard EUS. At CH-EUS, of the 11 lesions, 6 appeared hypoenhancing (colon cancer, sarcoma, and breast and ovarian cancer), 4 were hyperenhancing (renal cancer and lymphoma),and 1 was isoenhancing (melanoma).
In our population, standard EUS features of PM were unremarkable. At CH-EUS, most of the PM appeared hypoenhancing suggesting a possible malignant origin. However, a subset of PM showed hyperenhancing pattern. In the appropriate context, particularly when cancer history is present, CH-EUS may add to the differential diagnosis and potentially spare endoscopic ultrasonography with fine-needle aspiration.
原发性胰腺肿瘤与胰腺转移瘤(PM)的鉴别诊断具有挑战性。尽管内镜超声引导下细针抽吸术(EUS-FNA)在鉴别原发性与转移性肿瘤方面具有一定的作用,但准确性欠佳。最近,对比谐波超声内镜(CH-EUS)被报道可作为诊断胰腺肿瘤的辅助手段。我们评估了 CH-EUS 在 PM 鉴别诊断中的潜在作用。
这是一项前瞻性数据库的回顾性分析。在 266 例患者中,4.1%被诊断为 PM。EUS-FNA 和/或手术病理被认为是我们的标准。
PM 的来源为肾癌(3 例)、结肠癌(2 例)、乳腺癌(2 例)、卵巢癌(1 例)、黑色素瘤(1 例)、淋巴瘤(1 例)和肉瘤(1 例)。所有病变在标准 EUS 下均呈低回声。在 CH-EUS 下,11 个病灶中,6 个呈低增强(结肠癌、肉瘤和乳腺癌、卵巢癌),4 个呈高增强(肾癌、淋巴瘤),1 个呈等增强(黑色素瘤)。
在我们的人群中,PM 的标准 EUS 特征无明显特征。在 CH-EUS 下,大多数 PM 呈低增强,提示可能为恶性起源。然而,一部分 PM 表现出高增强模式。在适当的情况下,特别是当存在癌症病史时,CH-EUS 可能有助于鉴别诊断,并可能避免 EUS-FNA。